RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
An amyloidosis that is characterized by abnormal deposits of amyloid protein that mainly affect the eyes, nerves and skin and has_material_basis_in mutations in the gelsolin gene (GSN), and has_symptom corneal lattice dystrophy, has_symptom bilateral facial paralysis, has_symptom cutis laxa. (DO)
Synonyms:
exact_synonym:
AGel amyloidosis; Familial Amyloid Polyneuropathy Type Iv; Familial Amyloidosis, Finnish Type; Finnish type familial amyloid neuropathy; Kymenlaakso syndrome; Meretoja syndrome; Meretoja type amyloidosis; Meretoja's syndrome; amyloid cranial neuropathy with lattice corneal dystrophy; amyloidosis 5; amyloidosis V; amyloidosis due to mutant gelsolin; cerebral amyloid angiopathy, GSN-related; gelsolin amyloidosis; gelsolin-related Amyloidosis; lattice corneal dystrophy associated with familial systemic amyloidosis; lattice corneal dystrophy, Gelsolin type; lattice dystrophy of the cornea with hereditary generalized amyloidosis